KIET Calls for Tailored Support in Response to US Pharmaceutical Tariffs—Emphasizes Need to Enhance Domestic Technological Capabilities

South Korea’s KIET urges tailored support for domestic pharmaceutical exporters facing new US tariffs, highlighting the need to boost industry competitiveness and technological capabilities amid shifting US regulatory and trade policies.